DLB News 42.62 Dolby Laboratories (DLB)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Dolby Laboratories (DLB) 42.62 $DLB

Dolby Laboratories Announces Conference Call and Webcast for Q2 Fiscal 2014 Financial Results
Business Wire - Tue Apr 15, 8:01AM CDT
Dolby Laboratories, Inc. (NYSE: DLB) will release financial results for the second quarter (Q2) fiscal 2014 after the close of regular trading on Tuesday, April 29, 2014.

DTS Partners DivX - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 11:50AM CDT
A leading provider of high-definition audio solutions, DTS Inc. recently entered into a partnership with DivX.

28.4% Return Seen to Date on SmarTrend Dolby Laboratories Call (DLB)
Comtex SmarTrend(R) - Mon Apr 07, 11:04AM CDT
SmarTrend identified an Uptrend for Dolby Laboratories (NYSE LB) on September 17th, 2013 at $33.90. In approximately 7 months, Dolby Laboratories has returned 28.41% as of today's recent price of $43.53.

Frame Synchronizer Trends 2014
M2 - Wed Apr 02, 9:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tcbmbs/frame) has announced the addition of the "Frame Synchronizer Trends" report to their offering. Frame Synchronization, also known as framing, is a process to synchronize display-pixel scanning with a synchronization source. A Frame Synchronizer device is primarily utilized within live TV production for synchronizing the time of an incoming video source with that of an existing video system. The report analyzes and presents an overview of Frame Synchronizers market worldwide. The report highlights on various strategic industry activities of major companies witnessed by the industry over the last few years. Key Topics Covered: 1. FRAME SYNCHRONIZERS - TECHNOLOGY OVERVIEW - An Introduction 2. RECENT INDUSTRY ACTIVITY - AJA Video Systems Upgrades Software for FS2 Format Converter and Frame Synchronizer - FOR-A Unveils HVS-390HS Video Production Switcher - Harris Unveils HView SX Pro Multi-Display Management System - Snell Offers Frame Synchronization Capability on AHP of Sirius 800 Routing Switchers Range - EI Towers Selects Harris to Upgrade Harris Platinum Routing Solution - FOR-A to Showcase New Offerings at InfoComm Show 3. MARKET PARTICIPANTS - A.Telemetry Ltd. - Acroamatics, Inc. - ADAS - AJA Video Systems - Axon Digital Design BV - Blackmagic Design Pty., Ltd. - Burst Electronics, Inc. - Cobalt Digital, Inc. - Colorado Video, Inc. - Crystal Vision Ltd. - Delta Information Systems, Inc. - Dewesoft - Dolby Laboratories, Inc. - Ensemble Designs, Inc. - Evertz Microsystems Ltd. - GDP Space Systems - Grass Valley USA LLC - Harris Broadcast - Harris Corporation - Hotronic, Inc. - Kramer Electronics Ltd. - L-3 Telemetry-East - Link Electronics, Inc. - LYNX Technik AG - Miranda Technologies, Inc. - NVIDIA Corporation - Ross Video Ltd. - SAMS Elektronik D.o.o. - Snell Ltd. - Ulyssix Technology, Inc. 4. APPENDIX For more information visit http://www.researchandmarkets.com/research/tcbmbs/frame

Uptrend Call Working As Dolby Laboratories Stock Rises 32.1% (DLB)
Comtex SmarTrend(R) - Mon Mar 31, 9:41AM CDT
SmarTrend identified an Uptrend for Dolby Laboratories (NYSE LB) on September 17th, 2013 at $33.90. In approximately 7 months, Dolby Laboratories has returned 32.09% as of today's recent price of $44.78.

BT And Dolby Shake Up Enterprise Communications With Conference Calls That Sound Like In-Person Meetings
PR Newswire - Wed Mar 26, 9:56AM CDT
BT and Dolby Laboratories today announced the latest updates to BT® MeetMe with Dolby® Voice(TM), an audio conferencing service enhanced by the Dolby application that makes conference calls sound and feel like in-person meetings.

Elemental Demonstrates the Future of Video at NAB 2014
Business Wire - Wed Mar 26, 3:06AM CDT
Elemental Technologies, the leading supplier of software-defined video solutions for multiscreen content delivery, today announced its plans to demonstrate new functionality of its video processing platform at the National Association of Broadcasters (NAB) annual conference and exhibition in Las Vegas, April 7-10. The company will bring a host of software-based solutions to the show that give pay TV operators, content programmers, broadcasters and enterprise customers the ability to implement flexible and scalable video architectures for both traditional broadcast and multiscreen service offerings.

Cinemaxx to Roll Out 100 Dolby Atmos Screens in Indonesia
Business Wire - Mon Mar 24, 11:00AM CDT
CinemaCon 2014--Dolby Laboratories, Inc. (NYSE: DLB) and Lippo Group announced today that Cinemaxx, a new exhibitor under Indonesia's Lippo Group, has committed to installing Dolby Atmos in 100 cinema screens over the next three or more years, with 30 of the 100 screens scheduled to be launched by the end of May 2015. With this news, the revolutionary new Dolby Atmos(R) cinema sound format reaches a significant milestone: more than 600 screens worldwide have now been or are scheduled to be equipped for Dolby Atmos.

Guitammer Builds Theater Footprint & Broadcast Deals in 2013
ACCESSWIRE - Wed Mar 19, 9:52AM CDT
Whitefish, MT / March 19, 2014 / Imagine being able to physically feel the roar of an engine while watching a motorsports race on television or feeling the force from an explosion during an action movie. These sensations are quickly becoming a reality thanks to Guitammer Co.'s (OTCQB: GTMM) innovative low-frequency transducers that convert sound into tactile sensations. The ButtKicker brand technology has been installed across more than 100 cinemas with over 13,000 seats worldwide and has been growing in popularity among cinephiles and gamers in the at-home market.

DTS Earnings & Revs Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 19, 8:28AM CDT
DTS Inc. reported fourth quarter 2013 earnings of 35 cents per share, which missed the Zacks Consensus Estimate by a nickel.

31.8% Return Seen to Date on SmarTrend Dolby Laboratories Call (DLB)
Comtex SmarTrend(R) - Fri Mar 14, 4:53PM CDT
SmarTrend identified an Uptrend for Dolby Laboratories (NYSE LB) on September 17th, 2013 at $33.90. In approximately 6 months, Dolby Laboratories has returned 31.77% as of today's recent price of $44.67.

BT and Dolby Shake Up Enterprise Communications with Conference Calls that Sound like In-Person Meetings
Business Wire - Fri Mar 14, 8:00AM CDT
BT (NYSE:BT) and Dolby Laboratories, Inc. (NYSE LB) today announced the latest updates to BT(R) MeetMe with Dolby(R) Voice(TM) , an audio conferencing service that makes conference calls sound and feel like in-person meetings. BT MeetMe with Dolby Voice combines Dolby's nearly 50 years of expertise in core signal processing and human psychoacoustic perception with BT's world-class communications capabilities to improve the way people communicate at work, enhance business productivity, and reduce the cost of conferencing.

Completed Stock Offerings, Conference Participations, New Contracts, and Broader Array of Security Products - Analyst Notes on Plug Power, Dolby, NeuStar, Methode Electronics, and Control4
PR Newswire - Fri Mar 14, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Plug Power Inc. (NASDAQ: PLUG), Dolby Laboratories, Inc. (NYSE: DLB), NeuStar, Inc. (NYSE: NSR), Methode Electronics Inc. (NYSE: MEI), and Control4 Corporation (NASDAQ: CTRL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

4D Theaters Could Revive the Slowing 3D Market
ACCESSWIRE - Wed Mar 12, 9:06AM CDT
Whitefish, MT / March 12, 2014 / RealD (NYSE: RLD) CFO Drew Skarupa gave a speech, at the MKM Partners Investor Day Conference in September 2013, where he discussed the decline in 3D ticket sales over the past few years. In his presentation, Mr. Skarupa suggested that theatres should offer more 3D screens to stem the drop in overall attendance from 43% in 2012 to 33% in 2013.

3 Stocks Near 52-Week Highs Worth Selling
Sean Williams, The Motley Fool - Motley Fool - Thu Mar 06, 3:28PM CST
The beginning of the year swoon has decisively been put in the rearview mirror, with the broad-based S&P 500 launching itself to a new all-time high earlier this week on easing geopolitical fears. For skeptics like me, that's an opportunity to...

Financial Results Schedule, Stock Price Movements, Acquisitions, and Presentations - Analyst Notes on Plug Power, MicroVision, Dolby, Maxwell, and Sanmina
PR Newswire - Wed Mar 05, 8:17AM CST
Editor Note: For more information about this release, please scroll to bottom.

Shares of DLB Up 22.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Feb 28, 9:49AM CST
SmarTrend identified an Uptrend for Dolby Laboratories (NYSE LB) on September 17th, 2013 at $33.90. In approximately 5 months, Dolby Laboratories has returned 22.06% as of today's recent price of $41.38.

Adobe Commits Over $300 Million in Software and Teacher Training to President Obama's ConnectED Initiative
Business Wire - Fri Feb 28, 5:01AM CST
Adobe (Nasdaq:ADBE) today announced it is answering President Barack Obama's challenge to bring technology education and teacher training to American schools by committing over $300 million in software and professional development to the White House's ConnectED initiative. This commitment is among the largest to date, bringing the collective total of private sector donations to over $1 billion.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Macao's 25-Year Journey: Celebrating Growth and Prosperity

Updated Category News Views 161

Macao's Remarkable Development Over 25 Years In a vibrant celebration of progress, Macao recently marked the significant milestone of its 25th anniversary since its return to the motherland. A special publication by an English-language newspaper highlighted various achievements that the region has made during this transformative period. Economic Growth and Transformation...

Continue Reading
Opportunity to Address Losses: Join Tempus AI Class Action

Updated Category News Views 128

Investors Encouraged to Participate in Tempus AI Class Action The law firm Robbins Geller Rudman & Dowd LLP is actively reaching out to investors of Tempus AI, Inc. (NASDAQ: TEM) who have experienced notable financial losses. They have announced an opportunity for eligible investors to take the lead in an associated class action lawsuit. This potential action stems from...

Continue Reading
Muncy Columbia Financial Corporation's Strong Q4 2024 Earnings

Updated Category News Views 99

Muncy Columbia Financial Corporation's Financial Outlook Muncy Columbia Financial Corporation (“Corporation”) (OTCQX: CCFN), after releasing its unaudited consolidated financial statements for the fourth quarter of 2024, has demonstrated significant improvement over the previous year. Fourth Quarter 2024 Financial Highlights For the quarter ending December 31, 2024,...

Continue Reading
Caris Life Sciences Expands Cancer Research Alliance

Updated Category News Views 119

Caris Life Sciences Expands Cancer Research Alliance Caris Life Sciences® (NASDAQ: CAI), a forefront player in precision medicine and next-generation AI TechBio, is excited to share the arrival of Providence Swedish Cancer Institute into the esteemed Caris Precision Oncology Alliance (Caris POA). This addition enhances their collective mission to revolutionize cancer...

Continue Reading
Zumiez Inc. Gears Up for First Quarter 2025 Financial Report

Updated Category News Views 263

Upcoming Financial Report for Zumiez Inc. Zumiez Inc. (NASDAQ: ZUMZ) has recently made an exciting announcement regarding its financial performance. The company is set to release its first quarter results for fiscal 2025 on June 5, after the stock market closes. This pivotal moment is eagerly anticipated by investors and stakeholders alike, as it will provide valuable...

Continue Reading